JLE

European Journal of Dermatology

MENU

Post SARS-CoV-2 vaccination effluvium Volume 32, numéro 5, September-October 2022

Tableaux

Auteurs
Center for Dermatology and Hair Diseases, Bahnhofplatz 1A, 8304 Wallisellen, Switzerland

In December 2020, the FDA issued emergency use authorization for Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) SARS-CoV-2 vaccines. Cutaneous reactions reported after vaccination include: injection site reactions, urticarial and morbilliform eruptions, pernio/chilblains, reactions to cosmetic fillers, herpes zoster, herpes simplex flares, and pityriasis rosea-like rashes [1]. Reactions related to the hair have so far not been reported. We originally reported patients with COVID-19 [2], in whom [...]